Discontinued — last reported Q4 '25
Year-over-year, this metric declined by 100.0%, from $648.00M to $0.00.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $0.00 | $58.00M | $0.00 | $648.00M | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | -100.0% | — | -100.0% | — | — |
| YoY Change | — | — | — | — | -100.0% | — | -100.0% |